Holdings
Remedium Capital Partners, LLC
As of Jun 30, 2026, Remedium Capital Partners, LLC reported 6 positions worth US$452M. Largest: Oruka Therapeutics, Inc., Spyre Therapeutics, Inc. and Apogee Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 1.57M | US$149M | no change | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 1.46M | US$130M | +7,938 | Jun 30, 2026 |
| Apogee Therapeutics, Inc. | 587K | US$77.9M | +3,100 | Jun 30, 2026 |
| Damora Therapeutics, Inc. | 2.05M | US$53.2M | no change | Jun 30, 2026 |
| Jade Biosciences, Inc. | 1.58M | US$35.1M | no change | Jun 30, 2026 |
| Crescent Biopharma, Inc. | 361K | US$6.5M | new | Jun 30, 2026 |